IGF-1 LR3

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a modified analog of human IGF-1 engineered with a substitution of arginine at position 3 and an extended 13–amino acid N-terminal extension. These modifications reduce binding to IGF-binding proteins, resulting in a longer half-life and enhanced biological activity compared to native IGF-1.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.